M-alpha-HMCA
Jump to navigation
Jump to search
This article needs additional citations for verification. (June 2020) |
Identifiers | |
---|---|
| |
Chemical and physical data | |
Formula | C13H18N2O4 |
Molar mass | 266.13 g/mol (freebase) 239.78 g/mol (hydrochloride) g·mol−1 |
3D model (JSmol) | |
| |
|
M-alpha-HMCA (3-(benzo[d][1,3]dioxol-5-yl)-2-hydroxy-N,2-dimethyl-3-(methylamino)propanamide) is an unintentional sideproduct during the synthesis of MDMA using PMK glycidate as a precursor. It was identified in MDMA pills.[1] The biological properties of this molecule have not yet been documented. The backbone of the chemical structure is M-alpha whose psychoactive activity has been described by Alexander Shulgin.[citation needed]
References
- ^ Lee JH, Park OR, Mandava S, Kim J, Koo J, Lee J, Kang H (August 2020). "Identification of a new M-ALPHA analog and MDMA in an illegal health product". Forensic Science International. 313: 110332. doi:10.1016/j.forsciint.2020.110332. PMID 32540761.
Categories:
- Articles with short description
- Short description matches Wikidata
- Articles needing additional references from June 2020
- All articles needing additional references
- Use dmy dates from July 2015
- Chem-molar-mass both hardcoded and calculated
- Infobox-drug molecular-weight unexpected-character
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- All articles with unsourced statements
- Articles with unsourced statements from May 2022
- Amides
- Amines
- Benzodioxoles